Decision Diagnostics Corp.
DECNOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$35450
P/E Ratio—
52W High$0.0001
52W Low$0.0001
Decision Diagnostics Corp. (DECN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
DECN · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2021Report Date: Sep 30, 2021EPS Actual
-$0.00
Revenue
$0.00B
Fiscal Period
Q3 FY2021
FY ends December
Report Date
Sep 30, 2021
After Market Close
DECN reports quarterly as a OTC-listed Medical - Pharmaceuticals company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.11
Rev. $0.17B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.11
Rev. Est.$0.17B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q3 FY2021 | Sep 30, 2021 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2021 | Jun 30, 2021 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2021 | Jun 4, 2021 | — | -$0.00 | — | $0.00B | — | — |
| — Q4 FY2020 | Dec 31, 2020 | — | -$0.03 | — | $0.00B | — | — |
| — Q3 FY2020 | Sep 30, 2020 | — | -$0.02 | — | $0.00B | — | — |
| — Q2 FY2020 | Jun 30, 2020 | — | -$0.06 | — | $0.00B | — | — |
| — Q1 FY2020 | Mar 31, 2020 | — | -$0.00 | — | $0.00B | — | — |
| — Q4 FY2019 | Dec 31, 2019 | — | -$0.01 | — | $0.00B | — | — |
Q3 FY2021
Sep 30, 2021
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2021
Jun 30, 2021
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2021
Jun 4, 2021
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2020
Dec 31, 2020
EPS Actual
-$0.03
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2020
Sep 30, 2020
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2020
Jun 30, 2020
EPS Actual
-$0.06
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2020
Mar 31, 2020
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2019
Dec 31, 2019
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.54 | $1.54 | $1.54 | 1 |
| Q2 FY2024 | $1.34 | $1.34 | $1.34 | 1 |
| Q1 FY2024 | $1.58 | $1.58 | $1.58 | 1 |
| Q4 FY2023 | $2.09 | $2.09 | $2.09 | 1 |
| Q3 FY2023 | $1.39 | $1.39 | $1.39 | 1 |
| Q2 FY2023 | $1.19 | $1.19 | $1.19 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q3 FY2021 | Sep 30, 2021 | — | $0.00 | $0.00 | -70.00% |
| — Q2 FY2021 | Jun 30, 2021 | — | $0.00 | $0.01 | +150.00% |
| — Q2 FY2021 | Jun 4, 2021 | — | $0.01 | $0.01 | +0.00% |
| — Q4 FY2020 | Dec 31, 2020 | — | $0.00 | $0.02 | +5900.00% |
| — Q3 FY2020 | Sep 30, 2020 | — | $0.22 | $0.21 | -4.55% |
| — Q2 FY2020 | Jun 30, 2020 | — | $0.33 | $0.30 | -9.09% |
| — Q1 FY2020 | Mar 31, 2020 | — | $0.11 | $0.08 | -24.68% |
| — Q4 FY2019 | Dec 31, 2019 | — | $0.02 | $0.01 | -9.94% |
Q3 FY2021-70.00%
Report Date
Sep 30, 2021
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q2 FY2021+150.00%
Report Date
Jun 30, 2021
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.01
Q2 FY2021+0.00%
Report Date
Jun 4, 2021
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q4 FY2020+5900.00%
Report Date
Dec 31, 2020
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.02
Q3 FY2020-4.55%
Report Date
Sep 30, 2020
EPS Beat/Miss
—
Price Before
$0.22
Price After
$0.21
Q2 FY2020-9.09%
Report Date
Jun 30, 2020
EPS Beat/Miss
—
Price Before
$0.33
Price After
$0.30
Q1 FY2020-24.68%
Report Date
Mar 31, 2020
EPS Beat/Miss
—
Price Before
$0.11
Price After
$0.08
Q4 FY2019-9.94%
Report Date
Dec 31, 2019
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.01
Beat Rate0 / 8 quarters
Largest Move+5900.00% (Q4 FY2020)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: DECN ends December
Decision Diagnostics Corp. (DECN) most recently reported earnings on September 30, 2021 for Q3 FY2021, posting EPS of $-0.00 (in line with the analyst consensus of —). The next DECN earnings date is expected around September 1, 2026.
Each quarter, investors track DECN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DECN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DECN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
DECN earnings · 4 questionsDecision Diagnostics Corp.'s next earnings report is expected around September 1, 2026. DECN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DECN historically reports after market close (AMC).
DECN earnings datewhen is DECN earningsDECN next earnings datewhen does DECN report earningsDECN earnings calendar
▸ Source: FMP · Decision Diagnostics Corp. SEC filings · US GAAP · Decision Diagnostics Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026